Bristol-Myers pulls FDA application for combo lung cancer treatment

Emile Wamsteker | Bloomberg | Getty Images

A researcher in a Bristol-Myers Squibb laboratory. The drugs — ipilimumab (brand name Yervoy) and nivolumab (Opdivo) — belong to a class called checkpoint inhibitors and are made by Bristol-Myers Squibb.

Bristol-Myers Squibb said Thursday said it has voluntarily withdrawn its FDA application seeking approval for a drug combination to treat advanced lung cancer.

Source link

Leave a Comment

At least 20 dead in blasts at sports center in Afghan capitalIceland removed own label from 17 products rather than palm oil